Exploring the effect of minimally invasive surgery on patients with moderate-volume hypertensive intracerebral hemorrhage
探讨中少量高血压脑出血患者采用微创手术治疗的效果

摘要

目的 探讨微创手术治疗中少量高血压脑出血（HICH）患者的临床效果，为临床治疗方案选择提供参考。方法 选取2024年10月至2025年10月我院收治的100例中少量高血压脑出血患者，按治疗方式分为对照组和实验组，每组50例。对照组采用传统保守治疗，实验组采用微创手术治疗。比较两组患者临床疗效、神经功能缺损评分（NIHSS）、血肿清除率、住院时间及并发症发生率，并进行统计学分析。结果 实验组治疗总有效率94.00%，显著高于对照组的78.00%（P<0.05）；治疗后7d、14d，实验组NIHSS评分显著低于对照组（P<0.05）；实验组血肿清除率（89.63±5.27）%，显著高于对照组的（62.35±7.14）%，住院时间（14.23±3.15）d，显著短于对照组的（21.56±4.28）d（P<0.05）；实验组并发症发生率6.00%，显著低于对照组的20.00%（P<0.05）。结论 微创手术治疗中少量高血压脑出血患者，能提高血肿清除率，改善神经功能，缩短住院时间，降低并发症发生率，临床疗效显著，值得推广。

Abstract

Objective To explore the clinical effect of minimally invasive surgery in the treatment of patients with moderate-volume hypertensive intracerebral hemorrhage (HICH), and to provide a reference for clinical treatment plans.
Methods From October 2024 to October 2025, 100 patients with moderate-volume hypertensive intracerebral hemorrhage admitted to our hospital were selected and divided into the control group and the experimental group, with 50 cases in each group. The control group received traditional conservative treatment, while the experimental group received minimally invasive surgery. The clinical efficacy, neurological deficit score (NIHSS), hematoma clearance rate, hospital stay, and complication rate of the two groups were compared and statistically analyzed.
Results The total effective rate of the experimental group was 94.00%, significantly higher than that of the control group (78.00%) (P < 0.05); 7 days and 14 days after treatment, the NIHSS score of the experimental group was significantly lower than that of the control group (P < 0.05); the hematoma clearance rate of the experimental group was (89.63 ± 5.27)%, significantly higher than that of the control group (62.35 ± 7.14)%, and the hospital stay of the experimental group was (14.23 ± 3.15) days, significantly shorter than that of the control group (21.56 ± 4.28) days (P < 0.05); the complication rate of the experimental group was 6.00%, significantly lower than that of the control group (20.00%) (P < 0.05).
Conclusion   Minimally invasive surgery for patients with moderate-volume hypertensive intracerebral hemorrhage can improve hematoma clearance rate, improve neurological function, shorten hospital stay, and reduce complication rate, with significant clinical efficacy, and is worthy of promotion.